FLORHAM PARK, N.J., March 10 /PRNewswire/ -- Managed Health Care
Associates, Inc. (MHA) is pleased to announce the initial results of its
Specialty Pharmacy Member Profile initiative. MHA, the largest alternate
site GPO in the country, has been building a strong foundation related to
contracting for specialty pharmacy products. Through collaboration with the
MHA Specialty Pharmacy Advisory Board, and in partnership with key
specialty pharmaceutical manufacturers, MHA has developed the first
comprehensive data base identifying key attributes related to the ever
changing specialty pharmacy provider model. Manufacturers and payers have
provided input in terms of the value proposition they see related to the
specialty pharmacy marketplace today. Clearly identifying independent
specialty pharmacy providers and the in-depth services they provide has
been a major challenge for specialty pharmaceutical manufacturers.
Specialty pharmaceutical manufacturers have conveyed to MHA that this
information is essential to assist in developing specialty pharmacy
contracting strategies as it presents clear delineation and depth of
services provided by each respective specialty pharmacy.
MHA Specialty Pharmacy Program Highlights:
-- 130 independent specialty pharmacy providers completed the initial
-- Program participants represent over $320 Million in annualized
specialty drug spend
-- 41,000 patients serviced covering 15 unique disease states
-- Additional service model descriptions including payer profiles as well
as compliance and adherence programs
"We've had an overwhelmingly positive response to this program from both our specialty pharmacy members and specialty pharmaceutical manufacturer partners," stated Michael J. Sicilian, President of MHA. "We are confident this data will be highly valued in our continued discussions with the manufacturers of specialty pharmaceuticals to stratify and target providers for high cost, high tech biological drugs to treat chronic illnesses such as Rheumatoid Arthritis, Multiple Sclerosis, Cancer and Immune disorders. In the past, only large national pharmacy providers were identified as sources for these medications, but now as the market grows to over 60 billion dollars annually, many other specialty pharmacy models are emerging that can successfully provide these complex therapies. This profile tool will enable all MHA members, qualified to service these patients, to participate in MHA's specialty contracting with pharmaceutical manufacturers as this new Class of Trade continues to develop."
Richard Bulich, MHA Senior VP of Specialty Pharmacy added, "As the largest alternate site GPO servicing the Specialty and Home Infusion classes of trade, we will continue to leverage our expertise, size and reputation to capture a leading share of the ever expanding specialty pharmacy market. The value proposition to specialty pharmaceutical manufacturers is the ability to access unique data, not only at the patient level, but also in understanding the different specialty pharmacy service models within the existing marketplace. Specialty pharmacy has historically been driven through the mail order approach. With emerging specialty infusion, retail and long term care markets, MHA is uniquely positioned to bring additional value to its members and specialty pharmaceutical manufacturer partners. The Biotech drug pipeline is poised to release over 40 specialty drugs over the next 3 years, and MHA is establishing the key cornerstones to successfully service this market."
Managed Health Care Associates, Inc. (MHA) is the largest Alternate
Site GPO in the country servicing the Long Term Care, Home Infusion, Combo
Pharmacy and Specialty Pharmacy industries. MHA is also the leading Long
Term Care Pharmacy Network Manager with focus on serving the Medicare D
patient population. MHA's success is driven by unparalleled member support,
competitive contracts, and the ability to create sophisticated, customized,
web tools and reports, designed to increase savings and promote
profitability. Members utilize MHA services to assist in the purchasing of
a complete line of pharmaceuticals, medical supplies, capital equipment,
and nutritional food, as well as network access to the majority of the
largest national and regional prescription drug plans managing the Medicare
Part D drug benefit. MHA also offers a variety of other services including
contract administration, marketing, and continuing education. For more
information, visit http://www.mhainc.com.
For More Information Contact:
Director of Marketing
Managed Health Care Associates, Inc.
|SOURCE Managed Health Care Associates, Inc.|
Copyright©2008 PR Newswire.
All rights reserved